Daytryp provides highly effective psychedelic treatment options for people suffering from suicidal ideation. Our methods are beneficial especially for those who have tried traditional approaches without success. We provide each client with the resources necessary to make transformative and lasting changes.
This powerful healing journey happens under the medical supervision of a supportive and knowledgeable team. Our mission is to help you unlock your potential by interrupting the harmful pattern of suicidal thoughts and replacing it with new and healthy perceptions.
Research shows that ketamine is highly effective in treating PTSD, depression, addiction, alcoholism, anxiety, chronic pain, migraines, and eating disorders. The research and evidence is overwhelming that ketamine offers immediate relief of symptoms of all of these conditions. Studies also reveal that ketamine creates a path towards deep emotional healing that would lead someone to a better quality of life, thus eliminated suicidal ideation.
3,4-methylenedioxy-methamphetamine (MDMA) therapy is an upcoming, highly effective and innovative treatment approach for those suffering from post-traumatic stress disorder (PTSD) and other mental health conditions. It combines the psychoactive compound MDMA with guided psychological support, and has shown as much as a 75% success rate in patients suffering from PTSD, setting an unprecedented standard for treatment. MDMA therapy is not currently available, but expected to gain FDA approval later this year.
Submit an inquiry and our team will help you find the best treatment options for you.
Daytryp Health has taken The North Star Ethics Pledge, a commitment to a set of principles for individuals working professionally in the field of psychedelics and mental health. North Star is a nonprofit working to shape the psychedelic industry around psychedelic wisdom.
The Modern Spirit Reciprocity Project provides scholarships for Native Americans to receive ketamine-assisted therapy. Daytryp Health supports the ancestral cultures of this land with a vision for increased access to psychedelic-assisted therapy.